🇺🇸 FDA
Patent

US 8815951

Inhibitors of epoxide hydrolases for the treatment of inflammation

granted A61KA61K31/17A61K31/66

Quick answer

US patent 8815951 (Inhibitors of epoxide hydrolases for the treatment of inflammation) held by The Regents of the University of California expires Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Aug 26 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 21 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
11
CPC classes
A61K, A61K31/17, A61K31/66